189 results
Page 6 of 10
6-K
EX-99.1
odb929smktfahn2
23 Dec 19
RepliCel Announces its Incoming Board of Directors
5:21pm
6-K
EX-99.1
72zogvb19raxg r1e1
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.2
46id9qvsn3o7sc
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
zdumoff pj
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.1
w9dem
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.5
chrp86vp
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
r04w1ke
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
zhr9rg7htwvoj
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
5xinxjb
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
87oq08
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
lc381l
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
gnthhe7sc9rm5
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
as8xb3j
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
o04lxxv2tyns7qic
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.1
eba7l28pghh 5bohvcy
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.2
w5359tt0 tqs1j0
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
a5264e7lkt 10g
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
s4zvas1up5i9c ntji1s
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
jz40c8o
26 Mar 19
Current report (foreign)
1:45pm